1. Home
  2. MYNZ vs BMRA Comparison

MYNZ vs BMRA Comparison

Compare MYNZ & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNZ
  • BMRA
  • Stock Information
  • Founded
  • MYNZ 2021
  • BMRA 1971
  • Country
  • MYNZ Germany
  • BMRA United States
  • Employees
  • MYNZ N/A
  • BMRA N/A
  • Industry
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • MYNZ Health Care
  • BMRA Health Care
  • Exchange
  • MYNZ Nasdaq
  • BMRA Nasdaq
  • Market Cap
  • MYNZ 9.8M
  • BMRA 9.8M
  • IPO Year
  • MYNZ 2021
  • BMRA N/A
  • Fundamental
  • Price
  • MYNZ $0.48
  • BMRA $0.36
  • Analyst Decision
  • MYNZ Buy
  • BMRA
  • Analyst Count
  • MYNZ 2
  • BMRA 0
  • Target Price
  • MYNZ $3.00
  • BMRA N/A
  • AVG Volume (30 Days)
  • MYNZ 1.3M
  • BMRA 97.3K
  • Earning Date
  • MYNZ 08-13-2024
  • BMRA 08-23-2024
  • Dividend Yield
  • MYNZ N/A
  • BMRA N/A
  • EPS Growth
  • MYNZ N/A
  • BMRA N/A
  • EPS
  • MYNZ N/A
  • BMRA N/A
  • Revenue
  • MYNZ $895,479.00
  • BMRA $5,405,208.00
  • Revenue This Year
  • MYNZ $67.40
  • BMRA N/A
  • Revenue Next Year
  • MYNZ $191.13
  • BMRA N/A
  • P/E Ratio
  • MYNZ N/A
  • BMRA N/A
  • Revenue Growth
  • MYNZ 69.00
  • BMRA N/A
  • 52 Week Low
  • MYNZ $0.32
  • BMRA $0.28
  • 52 Week High
  • MYNZ $4.90
  • BMRA $2.13
  • Technical
  • Relative Strength Index (RSI)
  • MYNZ 47.27
  • BMRA 22.80
  • Support Level
  • MYNZ $0.39
  • BMRA $0.28
  • Resistance Level
  • MYNZ $0.56
  • BMRA $0.51
  • Average True Range (ATR)
  • MYNZ 0.09
  • BMRA 0.05
  • MACD
  • MYNZ 0.02
  • BMRA -0.00
  • Stochastic Oscillator
  • MYNZ 66.45
  • BMRA 33.43

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.

Share on Social Networks: